Neuromyelitis optica with hypothalamic involvement: A case report

Journal of the Medical Association of Thailand

Volumn 93, Issue 4, 2010, Pages 505-509

  Samart, Kusuma ^a   Phanthumchinda, Kammant ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Brain stem; Confabulation; Hypersomnia; Hypothalamic; Neuromyelitis optica

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; METHYLPREDNISOLONE;

ADULT; ARTICLE; BLURRED VISION; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CONFABULATION; CONSTIPATION; DISEASE DURATION; DRUG MEGADOSE; FEMALE; HUMAN; HYPERSOMNIA; HYPOTHALAMUS LESION; IMAGE ANALYSIS; LEUKOCYTE COUNT; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NECK PAIN; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; NYSTAGMUS; OPTIC NEURITIS; OSCILLOPSIA; PAIN; PLASMAPHERESIS; QUADRIPLEGIA; SENSORY DYSFUNCTION; SEPSIS; URINE RETENTION; VERTIGO; VISUAL ACUITY; WEAKNESS;

ADULT; FEMALE; HUMANS; HYPOTHALAMUS; NEUROMYELITIS OPTICA;

EID: 77951933489     PISSN: 01252208     EISSN: 01252208     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Jacob A, Matiello M, Wingerchuk DM, Lucchinetti F, Pittock SJ, Weinshenker BG. Neuromyelitis optica: changing concepts. J Neuroimmunol 2007; 187: 126-38.
2. Wingerchuk DM, Lennon VA, Pittock SJ, ucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006; 66: 1485-9.
3. Wingerchuk DM, Hogancamp WF, O'Brien PC, einshenker BG. The clinical course of neuro-myelitis optica (Devic's syndrome). Neurology 1999; 53: 1107-14.
4. Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock J, Lucchinetti CF, Fujihara K, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004; 364: 2106-12.
5. Takahashi T, Fujihara K, Nakashima I, Misu T, Miyazawa I, Nakamura M, et al. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. Brain 2007; 130: 1235-43.
6. Misu T, Fujihara K, Kakita A, Konno H, Nakamura M, Watanabe S, et al. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain 2007; 130: 1224-34.
7. Hinson SR, Pittock SJ, Lucchinetti CF, Roemer SF, Fryer JP, Kryzer TJ, et al. Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica. Neurology 2007; 69: 2221-31.
8. Pittock SJ, Weinshenker BG, Lucchinetti CF, Wingerchuk DM, Corboy JR, Lennon VA. Neuro-myelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol 2006; 63: 964-8.
9. Pittock SJ, Lennon VA, Krecke K, Wingerchuk DM, Lucchinetti CF, Weinshenker BG. Brain abnormalities in neuromyelitis optica. Arch Neurol 2006; 63: 390-6.
10. Ghezzi A, Bergamaschi R, Martinelli V, Trojano M, Tola MR, Merelli E, et al. Clinical characteristics, course and prognosis of relapsing Devic's Neuro-myelitis Optica. J Neurol 2004; 251: 47-52.
11. Poppe AY, Lapierre Y, Melancon D, Lowden D, Wardell L, Fullerton LM, et al. Neuromyelitis optica with hypothalamic involvement. Mult Scler 2005; 11: 617-21.
12. Vernant JC, Cabre P, Smadja D, Merle H, Caubarrere I, Mikol J, et al. Recurrent optic neuromyelitis with endocrinopathies: a new syndrome. Neurology 1997; 48: 58-64.
13. Nakamura M, Miyazawa I, Fujihara K, Nakashima I, Misu T, Watanabe S, et al. Preferential spinal central gray matter involvement in neuromyelitis optica. An MRI study. J Neurol 2008; 255: 163-70.
14. Keegan M, Pineda AA, McClelland RL, Darby CH, Rodriguez M, Weinshenker BG. Plasma exchange for severe attacks of CNS demyelination: predictors of response. Neurology 2002; 58: 143-6.